Severe placental lesions due to maternal SARS-CoV-2 infection associated to intrauterine fetal death

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human pathology 2022-03, Vol.121, p.46-55
Hauptverfasser: Dubucs, Charlotte, Groussolles, Marion, Ousselin, Jessie, Sartor, Agnès, Van Acker, Nathalie, Vayssière, Christophe, Pasquier, Christophe, Reyre, Joëlle, Batlle, Laïa, Favarel clinical research associate, Stèphanie, Duchanois midwife, Delphine, Jauffret clinical research associate, Valèrie, Courtade-Saïdi, Monique, Aziza, Jacqueline
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can cause severe placental lesions leading rapidly to intrauterine fetal death (IUFD). From August 2020 to September 2021, in the pathology department of Toulouse Oncopole, we analyzed 50 placentas from COVID-19–positive unvaccinated mothers. The purpose of our study is to describe the clinicopathological characteristics of these placental damages and to understand the pathophysiology. Ten of them (20%) showed placental lesions with positive immunohistochemistry for SARS-CoV-2 in villous trophoblasts. In five cases (10%), we observed massive placental damage associating trophoblastic necrosis, fibrinous deposits, intervillositis, as well as extensive hemorrhagic changes due to SARS-CoV-2 infection probably responsible of IUFD by functional placental insufficiency. In five other cases, we found similar placental lesions but with a focal distribution that did not lead to IUFD but live birth. These lesions are independent of maternal clinical severity of COVID-19 infection because they occur despite mild maternal symptoms and are therefore difficult to predict. In our cases, they occurred 1–3 weeks after positive SARS-CoV-2 maternal real-time polymerase chain reaction testing and were observed in the 2nd and 3rd trimesters of pregnancies. When these lesions are focal, they do not lead to IUFD and can be involved in intrauterine growth restriction. Our findings, together with recent observations, suggest that future pregnancy guidance should include stricter pandemic precautions such as screening for a wider array of COVID-19 symptoms, enhanced ultrasound monitoring, as well as newborn medical surveillance. •Maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can generate severe placental lesions.•Some COVID-19–positive unvaccinated mothers show trophoblastic necrosis with positive anti-SARS-CoV-2 immunohistochemitrsy.•SARS-CoV-2 placental lesions can be involved in intrauterine fetal death (10% of cases) when placental damage is massive.•Intrauterine fetal death occurred 1–3 weeks after maternal infection in 2nd and 3rd trimesters of pregnancies.•Severe SARS-CoV-2 placenta lesions occur despite mild maternal COVID-19 symptoms.
ISSN:0046-8177
1532-8392
DOI:10.1016/j.humpath.2021.12.012